Comprehensive Adolescent Recruitment & Engagement Strategies – CARES

Funded by the National Institute of Child Health and Human Development (NICHD)

Adolescent Trials Network (ATN) Project Summary

America’s increasing HIV epidemic among youth aged 12-24 and our concurrent failure to identify, link to care, and achieve viral suppression among youth living with HIV (YLH) suggests the need to identify novel community-based strategies to leverage gateways and settings where high risk and infected youth can be engaged in HIV prevention and treatment. Scientific successes reducing HIV viral reservoirs among acutely infected infants, stopping HIV transmission from HIV-infected adults with undetectable viral loads, and documenting the efficacy of Treatment as Prevention (TASP) suggest strategies to reduce the trend of increasing adolescent HIV infections. This U19 will evaluate the usefulness of these advances for youth aged 12-24 at the highest risk of acquiring HIV- gay, bisexual, transgender youth (GBTY) and homeless youth (HY) – as well as youth living with HIV (YLH) in two HIV epicenters (Los Angeles and New Orleans).

The CARES includes two Cores:
Management Core (led by Dr. Mary Jane Rotheram)

The Management Core is responsible for leadership and networking; communication and problem resolution; administration; and, implementation of the Recruitment, Engagement, and Retention Centers (RERC) in Los Angeles and New Orleans that identify, recruit and retain all participants and samples for the CARES studies. The Management Core establishes the goals, timelines, monitors deliverables, sets strategies for quality improvement over time, training, and coordination of teams over time.

Analytic Core (led by Dr. Scott Comulada)

The Analytic Core provides methodological and statistical support across the CARES studies from inception to completion, including study design development, data collection, and analysis. The Analytic Core provides a range of technological, biomedical, and behavioral research expertise including fitting complex multilevel models to HIV data with both behavioral and biomarker outcomes, implementation science and cost-effectiveness. The Analytic Core is also be responsible data management, monitoring, security and dissemination. The Analytic Core has expertise in cost effectiveness and cost-utility analyses, as well as substantial experience with interventions mounted on social media sites, and using mobile and computerized interventions. 

All GBTY and HY at five gay-identified community-based organizations (CBO) and homeless shelters will be screened over 18 months. From these screenings, a cohort of 220 YLH and 1,500 highest risk seronegative GBTY and HY will be formed. Over 24 months, this cohort will be repeatedly tested at four month intervals for sexually transmitted infections (STI) and serious drug use, and with 4th Gen HIV tests if seronegative, in order to identify acutely infected youth, engage youth in medical care, and monitor outcomes. Youth are triaged to:

Study 1: Acute infection. Using 36 ARV-naïve YLH with established infection as controls, we expect to identify 36 YLH with acute infection. All youth with acute infections will be aggressively treated with at least four highly potent antiretroviral therapies (ARV) and repeatedly assessed to examine if prolonged viral suppression is achieved, with reduced viral reservoirs to potentially allow ARV- free HIV remission.

Study 2: Stepped care for YLH. Adapting strategies to manage chronic illnesses, we will conduct a RCT comparing a Standard Care Arm (repeated assessments every four month and an Automated Messaging and Monitoring Intervention [AMMI]) to Stepped Care. In the Stepped Care Arm, increasingly more intense interventions are delivered if viral load is detectable: a) the Standard Care Arm; b) an AMMI that is tailored to comorbidities of the specific YLH; or c) a Coach to support during crises, make treatment referrals, and brief interventions. Dried blood spots will monitor viral load and, on a small sample, ARV adherence over time.

Click here for the presentation slides

Study 3: Engaging seronegative youth in the HIV Prevention Continuum. Youth will be randomized to either: a) an AMMI Arm; b) Peer-Support plus AMMI Arm; c) eNavigator and an AMMI arm; or d) Peer-Support plus eNavigator plus AMMI Arm. Each condition aims to optimize the HIV Prevention Continuum.

An interdisciplinary team of basic, clinical, and applied researchers with expertise in HIV, STI, behavioral interventions, biomedical interventions, CURE research, perinatal HIV, and a history of participating and coordinating multi-site RCT is participating on this U19 from six universities.

Management Core    
Mary Jane Rotheram, Ph.D. UCLA Management Core
Isa Fernandez, Ph.D. Nova Southeastern University Management/Study 2
Yvonne Bryson, M.D. UCLA Management/Study 1
Sue Ellen Abdalia, M.D. Tulane University Manegement/Study 1, 2 & 3
Jeff Klausner M.D. UCLA Management Core
Jody Kussin, Ph.D. UCLA Management Core
     
RERC    
Sung-Jae Lee, Ph.D. UCLA RERC
Maryann Koussa, MPH UCLA RERC
Leslie Kozina,R.N., CCRC Tulane University RERC/Study 1, 2 & 3
Thomas Davis UCLA RERC
Emmanuel Ares UCLA RERC
Oscar Salinas, MD Tulane University RERC/Study 3
Jasmine Fournier, MS Tulane University RERC/Study 2 & 3
Lisa Cunningham, MSE,CCRP Tulane University RERC/Study 1, 2 & 3
     
Analytic Core    
Scott Comulada, Ph.D. UCLA Analytic Core
Rob Weiss, Ph.D. UCLA Analytic Core
Ron Brookmeyer, Ph.D. UCLA Analytic Core
Chunqing Lin, Ph.D. UCLA Analytic Core
Wenze Tang UCLA Analytic Core
Tom Weichle, MS UCLA Analytic Core
     
Study 1    
Karin Nielsen. M.D. UCLA Study 1
Tara Kerin, Ph.D. UCLA Study 1
Kate Mitchell UCLA Study 1
Ruth Cortado UCLA Study 1
Chelsea Shannon UCLA Study 1&3
Brenda Andrews, RN, MSN Tulane Study 1&2
Trina Jeanjacques, MSW Tulane Study 1&2
     
Study 2    
Elizabeth Arnold, Ph.D. Wake Forest University Study 2
Patrick Wilson, Ph.D. Columbia University Study 2
Norweeta Milburn, Ph.D. UCLA Study 2
Li Li, Ph.D. UCLA Study 2
Barbara Lasater Wake Forest University Study 2
Toria Jones Tulane Study 2&3
     
Study 3    
Dallas Swendeman, Ph.D. UCLA Study 3
Cathy Reback, Ph.D. UCLA Study 3
Marguerita Lightfoot, Ph.D. UCSF Study 3
Sean Young, Ph.D. UCLA Study 3
Danielle Harris, MPH/MA UCLA Study 3
Antwon Chaplin UCLA Study 3
Sean Sylve, CPhT Tulane University Study 3